The increasing incidence of type 2 diabetes mellitus is partially due to the rising obesity rates and the elevated levels of free fatty acids (FFAs). It is known that FFAs are putative mediators of beta-cell dysfunction, which is characterized with impaired glucose-stimulated insulin secretion and increased apoptosis, being defined as lipotoxicity. To date, many factors and their related signal pathways have been reported to be involved in FFA-induced beta-cell dysfunction. However, the entire blueprint is still not obtained. Some essential and newfound effectors, including the sterol regulatory element-binding protein (SREBP)-1c, farnesoid X receptor (FXR), forkhead box-containing protein O (FoxO) 1, ubiquitin C-terminal hydrolase L (UCHL) 1, N-myc downstream-regulated gene (NDRG) 2, perilipin family proteins, silent information regulator 2 protein 1 (Sirt1), pituitary adenylate cyclase-activating polypeptide (PACAP), and ghrelin are described in this review, which may help to further understand the molecular network for lipotoxicity.
BorgJ., KlintC., WierupN., StromK., LarssonS., SundlerF., LupiR., MarchettiP., XuG., KimmelA., LondosC., HolmC.2009. Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1. Endocrinology, 150:3049–3057.
6.
BrasaemleD.L.2007. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res, 48:2547–2559.
7.
ChenY.R., FangS.R., FuY.C., ZhouX.H., XuM.Y., XuW.C.2010. Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. Biochem Cell Biol, 88:715–722.
8.
ChoiJ., LeveyA.I., WeintraubS.T., ReesH.D., GearingM., ChinL.S., LiL.2004. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem, 279:13256–13264.
9.
ChongZ.Z., ShangY.C., WangS., MaieseK.2012. SIRT1: new avenues of discovery for disorders of oxidative stress. Expert Opin Ther Targets, 16:167–178.
10.
ChuK.Y., LiH., WadaK., JohnsonJ.D.2012. Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions. Diabetologia, 55:128–140.
11.
CohenH.Y., MillerC., BittermanK.J., WallN.R., HekkingB., KesslerB., HowitzK.T., GorospeM., de CaboR., SinclairD.A.2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 305:390–392.
12.
DezakiK., HosodaH., KakeiM., HashiguchiS., WatanabeM., KangawaK., YadaT.2004. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes, 53:3142–3151.
13.
DucharmeN.A., BickelP.E.2008. Lipid droplets in lipogenesis and lipolysis. Endocrinology, 149:942–949.
14.
DuferM., HorthK., Krippeit-DrewsP., DrewsG.2012. The significance of the nuclear farnesoid X receptor (FXR) in beta cell function. Islets, 4:333–338.
15.
FaleckD.M., AliK., RoatR., GrahamM.J., CrookeR.M., BattistiR., GarciaE., AhimaR.S., ImaiY.2010. Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets. Am J Physiol Endocrinol Metab, 299:249–257.
16.
FangD., HuangZ., GuanH., LiuJ., YaoB., XiaoH., LiY.2012. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells. Mol Med Report, 5:233–238.
17.
FilipssonK., TornoeK., HolstJ., AhrenB.1997. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J Clin Endocrinol Metab, 82:3093–3098.
18.
FolettaV.C., PriorM.J., StupkaN., CareyK., SegalD.H., JonesS., SwintonC., MartinS., Cameron-SmithD., WalderK.R.2009. NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol, 587:1619–1634.
19.
ForcheronF., LegedzL., ChinettiG., FeugierP., LetexierD., BriccaG., BeylotM.2005. Genes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression. Arterioscler Thromb Vasc Biol, 25:1711–1717.
20.
GiaccaA., XiaoC., OprescuA.I., CarpentierA.C., LewisG.F.2011. Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab, 300:E255–E262.
21.
GranataR., SettanniF., BianconeL., TrovatoL., NanoR., BertuzziF., DestefanisS., AnnunziataM., MartinettiM., CatapanoF., GheC., IsgaardJ., PapottiM., GhigoE., MuccioliG.2007. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology, 148:512–529.
22.
HaigisM.C., GuarenteL.P.2006. Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev, 20:2913–2921.
23.
HeidH.W., MollR., SchwetlickI., RackwitzH.R., KeenanT.W.1998. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res, 294:309–321.
24.
HershkoA., CiechanoverA., VarshavskyA.2000. Basic Medical Research Award. The ubiquitin system. Nat Med, 6:1073–1081.
25.
HongS.W., LeeJ., ParkS.E., RheeE.J., ParkC.Y., OhK.W., ParkS.W., LeeW.Y.2012. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic beta-cell line. Mol Cell Endocrinol, 362:242–252.
26.
HuX.L., LiuX.P., DengY.C., LinS.X., WuL., ZhangJ., WangL.F., WangX.B., LiX., ShenL., ZhangY.Q., YaoL.B.2006. Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues. Cell Tissue Res, 325:67–76.
27.
ImaiY., VarelaG.M., JacksonM.B., GrahamM.J., CrookeR.M., AhimaR.S.2007. Reduction of hepato-steatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology, 132:1947–1954.
28.
KaestnerK.H., KnochelW., MartinezD.E.2000. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev, 14:142–146.
29.
KatoT., ShimanoH., YamamotoT., IshikawaM., KumadakiS., MatsuzakaT., NakagawaY., YahagiN., NakakukiM., HastyA.H., TakeuchiY., KobayashiK., TakahashiA., YatohS., SuzukiH., SoneH., YamadaN.2008. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes, 57:2382–2392.
30.
KikuchiO., KobayashiM., AmanoK., SasakiT., KitazumiT., KimH.J., LeeY.S., Yokota-HashimotoH., KitamuraY.I., KitamuraT.2012. FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization. PLoS One, 7:e32249.
31.
KimS.J., WinterK., NianC., TsuneokaM., KodaY., McIntoshC.H.2005. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem, 280:22297–22307.
32.
KitamuraT., NakaeJ., KitamuraY., KidoY., BiggsW.H.3rd, WrightC.V., WhiteM.F., ArdenK.C., AcciliD.2002. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest, 110:1839–1847.
33.
LachatP., ShawP., GebhardS., van, BelzenN., ChaubertP., BosmanF.T.2002. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol, 118:399–408.
34.
LeeC.S., SundN.J., VatamaniukM.Z., MatschinskyF.M., StoffersD.A., KaestnerK.H.2002. Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes, 51:2546–2551.
35.
LefebvreP., CariouB., LienF., KuipersF., StaelsB.2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev, 89:147–191.
36.
LiY., XuS., GilesA., NakamuraK., LeeJ.W., HouX., DonmezG., LiJ., LuoZ., WalshK., GuarenteL., ZangM.2011. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J, 25:1664–1679.
37.
Lopez-AvalosM.D., Duvivier-KaliV.F., XuG., Bonner-WeirS., SharmaA., WeirG.C.2006. Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes, 55:1223–1231.
38.
MaK., SahaP.K., ChanL., MooreD.D.2006. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest, 116:1102–1109.
39.
MakishimaM., OkamotoA.Y., RepaJ.J., TuH., LearnedR.M., LukA., HullM.V., LustigK.D., MangelsdorfD.J., ShanB.1999. Identification of a nuclear receptor for bile acids. Science, 284:1362–1365.
40.
MartinezS.C., TanabeK., Cras-MeneurC., AbumradN.A., Bernal-MizrachiE., PermuttM.A.2008. Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes, 57:846–859.
41.
MeetooD., McGovernP., SafadiR.2007. An epidemiological overview of diabetes across the world. Br J Nurs, 16:1002–1007.
42.
MishraR., SimonsonM.S.2005. Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptoticsignaling involving caspase 9 and mitochondrial release of endonuclease G. Cardiovasc Diabetol, 10:2.
43.
MiuraS., GanJ.W., BrzostowskiJ., ParisiM.J., SchultzC.J., LondosC., OliverB., KimmelA.R.2002. Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J Biol Chem, 30:32253–32257.
44.
MiyazakiS., MinamidaR., FuruyamaT., TashiroF., YamatoE., InagakiS., MiyazakiJ.2012. Analysis of Foxo1-regulated genes using Foxo1-deficient pancreatic beta cells. Genes Cells, 17:758–767.
45.
MoynihanK.A., GrimmA.A., PluegerM.M., Bernal-MizrachiE., FordE., Cras-MeneurC., PermuttM.A., ImaiS.2005. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab, 2:105–117.
46.
NakataM., ShintaniN., HashimotoH., BabaA., YadaT.2010. Intra-islet PACAP protects pancreatic beta-cells against glucotoxicity and lipotoxicity. J Mol Neurosci, 42:404–410.
47.
NakataM., YadaT.2007. PACAP in the glucose and energy homeostasis: physiological role and therapeutic potential. Curr Pharm Des, 13:1105–1112.
48.
NijmanS.M., Luna-VargasM.P., VeldsA., BrummelkampT.R., DiracA.M., SixmaT.K., BernardsR.2005. A genomic and functional inventory of deubiquitinating enzymes. Cell, 123:773–786.
49.
PopescuI.R., Helleboid-ChapmanA., LucasA., VandewalleB., DumontJ., BouchaertE., DerudasB., Kerr-ConteJ., CaronS., PattouF., StaelsB.2010. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett, 584:2845–2851.
50.
PicardF., KurtevM., ChungN., Topark-NgarmA., SenawongT., Machado, De OliveiraR., LeidM., McBurneyM.W., GuarenteL.2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature, 429:771–776.
51.
PradoC.L., Pugh-BernardA.E., ElghaziL., Sosa-PinedaB., SusselL.2004. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A, 101:2924–2929.
52.
RamseyK.M., MillsK.F., SatohA., ImaiS.2008. Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell, 7:78–88.
53.
SakuraiY., ShintaniN., HayataA., HashimotoH., BabaA.2011. Trophic effects of PACAP on pancreatic islets: a mini-review. J Mol Neurosci, 43:3–7.
54.
ShaoS., FangZ., YuX., ZhangM.2009. Transcription factors involved in glucose-stimulated insulin secretion of pancreatic beta cells. Biochem Biophys Res Commun, 384:401–404.
55.
ShaoS., LiuZ., YangY., ZhangM., YuX.2010. SREBP-1c, Pdx-1, and GLP-1R involved in palmitate-EPA regulated glucose-stimulated insulin secretion in INS-1 cells. J Cell Biochem, 111:634–642.
56.
ShenL., ZhaoZ.Y., WangY.Z., JiS.P., LiuX.P., LiuX.W., CheH.L., LinW., LiX., ZhangJ., YaoL.B.2008. Immunohistochemical detection of Ndrg2 in the mouse nervous system. Neuroreport, 19:927–931.
57.
ShenL., LiuX., HouW., YangG., WuY., ZhangR., LiX., CheH., LuZ., ZhangY., YaoL.2010. NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity. Cell Mol Life Sci, 67:1371–1381.
58.
SoaresJ.B., Leite-MoreiraA.F.2008. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides, 29:1255–1270.
59.
SoaresJ.B., Leite-MoreiraA.F.2008. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides, 29:1255–1270.
60.
SunY., AsnicarM., SahaP.K., ChanL., SmithR.G.2006. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab, 3:379–386.
61.
SunC., ZhangF., GeX., YanT., ChenX., ShiX., ZhaiQ.2007. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab, 6:307–319.
VetterliL., BrunT., GiovannoniL., BoscoD., MaechlerP.2011. Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. J Biol Chem, 286:6049–6060.
65.
VignjevićS., TodorovićV., DamjanovićS., BudečM., MitrovićO., DjikićD., DrndarevićN., MićićM., Mišković-KrivokapićJ., DjuričićS., NikolićI.2012. Similar Developmental Patterns of Ghrelin- and Glucagon-Expressing Cells in the Human Pancreas. Cells Tissues Organs, 196:362–373.
66.
WangW., LiuY., ChenY., CaoC., XiangY., ZhangD., HanL., ZhaoH., LiuG.2010. Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic beta-cells. Peptides, 31:307–314.
